Yeul Hong Kim, MD, PhD is Professor of Medical Oncology at the Korea University College of Medicine as well as Director of the Korea University Cancer Institute. He is certified in internal medicine and medical oncology by the Korean Association of Internal Medicine.
Dr. Kim is primarily interested in the chemotherapy of stomach cancer, colon cancer and other gastrointestinal cancers including pancreatic cancer and biliary cancer. He is actively involved in the Cancer Genomic research for lung and gastrointestinal cancers using microarray, proteomics, and NGS analysis. He is a pioneer in Korea in the area of liquid biopsy using circulating tumor DNA isolated from cancer patient’s blood. He is President of Asian Oncology Society. Currently he is Director of the Korean Precision Medicine Enterprise, which is funded from Korea Ministry of Health and Welfare. He has published 176 papers in SCI or SCIE listed peer-reviewed medical journals including Nature Genetics, Lancet, Journal of Clinical Oncology, Clinical Cancer Research, etc..